These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2295 related articles for article (PubMed ID: 28360349)

  • 21. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
    Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
    Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Microbiome, diabetes and heart: a novel link?].
    Kappel BA; Lehrke M
    Herz; 2019 May; 44(3):223-230. PubMed ID: 30847506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation.
    Tousoulis D; Guzik T; Padro T; Duncker DJ; De Luca G; Eringa E; Vavlukis M; Antonopoulos AS; Katsimichas T; Cenko E; Djordjevic-Dikic A; Fleming I; Manfrini O; Trifunovic D; Antoniades C; Crea F
    Cardiovasc Res; 2022 Dec; 118(16):3171-3182. PubMed ID: 35420126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota in cardiovascular disease and heart failure.
    Kitai T; Tang WHW
    Clin Sci (Lond); 2018 Jan; 132(1):85-91. PubMed ID: 29326279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk.
    Koopen AM; Groen AK; Nieuwdorp M
    Curr Opin Lipidol; 2016 Dec; 27(6):615-622. PubMed ID: 27676197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics.
    Griffin JL; Wang X; Stanley E
    Circ Cardiovasc Genet; 2015 Feb; 8(1):187-91. PubMed ID: 25691688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
    Trøseid M; Andersen GØ; Broch K; Hov JR
    EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
    Belli M; Barone L; Longo S; Prandi FR; Lecis D; Mollace R; Margonato D; Muscoli S; Sergi D; Federici M; Barillà F
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis.
    Li D; Kirsop J; Tang WH
    Curr Diab Rep; 2015 Sep; 15(9):63. PubMed ID: 26208694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity.
    Bu J; Wang Z
    Gastroenterol Res Pract; 2018; 2018():6458094. PubMed ID: 29967639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota.
    Alhajri N; Khursheed R; Ali MT; Abu Izneid T; Al-Kabbani O; Al-Haidar MB; Al-Hemeiri F; Alhashmi M; Pottoo FH
    Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Microbiota and Cardiovascular Diseases: A Critical Review.
    Anselmi G; Gagliardi L; Egidi G; Leone S; Gasbarrini A; Miggiano GAD; Galiuto L
    Cardiol Rev; 2021 Jul-Aug 01; 29(4):195-204. PubMed ID: 32639240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis.
    Manolis AA; Manolis TA; Melita H; Manolis AS
    Curr Med Chem; 2022; 29(23):4050-4077. PubMed ID: 34961453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine organs of cardiovascular diseases: Gut microbiota.
    Jia Q; Xie Y; Lu C; Zhang A; Lu Y; Lv S; Zhang J
    J Cell Mol Med; 2019 Apr; 23(4):2314-2323. PubMed ID: 30688023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 115.